CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


CRI managementWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug2233 Serological analyses to be lead on a pre-existing biobank Wiki 1.00

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D001172 Arthritis, Rheumatoid NIH 0.38
D001168 Arthritis NIH 0.29

Correlated HPO Terms (2)


Name (Synonyms) Correlation
HP:0001370 Rheumatoid arthritis HPO 0.38
HP:0001369 Arthritis HPO 0.29

There is one clinical trial.

Clinical Trials


1 CRI and Continuous Assessment of Hemodynamic Compensation to Guide Fluid and Pressor Management in Severely Ill Patients With COVID-19

The FDA has approved the CipherOx CRI T1 Tablet for use in subjects aged 19-36, and that this study aims to evaluate the device in subjects aged outside of this range and is being used off label. The FDA determined the Cipher OX CRI T1 Tablet to be a class II device in 2016, and additional research has been done since the FDA determination to further support the use of the device outside of its current labeling.

NCT04457817 COVID Device: CRI management

Primary Outcomes

Description: Volume of IV fluid infused during treatment

Measure: Volume of IV fluid infused

Time: 1 year

Description: Amount of blood pressure medication utilized during treatment

Measure: Quantity of Blood pressure medication administered

Time: 1 year

Description: Categorical determination of resuscitation status as over- or under- resuscitated

Measure: Resuscitation status

Time: 1 year

Description: FiO2 levels administered

Measure: FiO2 needs

Time: 1 year

Description: Days spent on oxygen

Measure: Days on Oxygen

Time: 1 year

Description: Number of participants with hospital acquired pneumonia

Measure: Number of participants with hospital acquired pneumonia

Time: 1 year

Description: Number of patients who acquire an acute kidney injury

Measure: Number of Patients with Acute Kidney Injury (AKI)

Time: 1 year

Description: Number of patients who experience hemodynamic collapse defined as drop in systolic blood pressure below 80mm Hg

Measure: Number of patients with hemodynamic collapse

Time: 1 year

Description: Number of patients who experience mortality

Measure: mortality

Time: 1 year


No related HPO nodes (Using clinical trials)